A detailed history of Meridian Wealth Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Meridian Wealth Partners, LLC holds 3,355 shares of ABT stock, worth $380,356. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,355
Previous 3,253 3.14%
Holding current value
$380,356
Previous $369,000 5.69%
% of portfolio
0.06%
Previous 0.07%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$100.73 - $112.44 $10,274 - $11,468
102 Added 3.14%
3,355 $348,000
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $17,194 - $18,990
157 Added 5.07%
3,253 $369,000
Q4 2023

Feb 05, 2024

BUY
$90.19 - $110.4 $23,629 - $28,924
262 Added 9.24%
3,096 $340,000
Q3 2023

Nov 03, 2023

SELL
$95.53 - $114.62 $18,437 - $22,121
-193 Reduced 6.38%
2,834 $274,000
Q2 2023

Aug 02, 2023

BUY
$100.78 - $112.29 $26,001 - $28,970
258 Added 9.32%
3,027 $330,000
Q1 2023

May 04, 2023

SELL
$96.86 - $114.01 $14,625 - $17,215
-151 Reduced 5.17%
2,769 $280,000
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $274,628 - $322,181
-2,889 Reduced 49.73%
2,920 $320,000
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $220,032 - $254,756
-2,274 Reduced 28.13%
5,809 $562,000
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $42,052 - $50,828
412 Added 5.37%
8,083 $878,000
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $29,303 - $35,733
257 Added 3.47%
7,671 $908,000
Q4 2021

Feb 15, 2022

BUY
$115.53 - $141.46 $3,581 - $4,385
31 Added 0.42%
7,414 $1.04 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $4,549 - $5,033
39 Added 0.53%
7,383 $872,000
Q2 2021

Aug 12, 2021

SELL
$105.79 - $124.53 $1,798 - $2,117
-17 Reduced 0.23%
7,344 $851,000
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $5,659 - $6,667
52 Added 0.71%
7,361 $882,000
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $42,210 - $45,996
-402 Reduced 5.21%
7,309 $801,000
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $3,573 - $4,340
39 Added 0.51%
7,711 $839,000
Q2 2020

Aug 12, 2020

SELL
$76.57 - $98.0 $306 - $392
-4 Reduced 0.05%
7,672 $701,000
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $1,005 - $1,469
16 Added 0.21%
7,676 $606,000
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $601,386 - $669,484
7,660 New
7,660 $665,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Meridian Wealth Partners, LLC Portfolio

Follow Meridian Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Wealth Partners, LLC with notifications on news.